Merck & Co. ($MRK) is facing another supply interruption for its ovulation-stimulating hormone Follistim, and like the supply lapse from several years ago, Merck has little to say.nnA notice on the American Society of Health-System Pharmacists (ASHP) website indicates the drugmaker said in mid-May that all dose forms of its Follistim AQ Cartridges were on backorder but didn’t give a reason.
The WHO hopes Syrian authorities will soon let it ship surgical supplies to Moadamiyeh after a consignment of antibiotics and painkillers was allowed into the besieged city.
SA’s medicine supply crisis
SA running out of penicillin